大麻消费和喘风险:系统审查和元分析
Ajay Malvi1, Mahalaqua Nazli Khatib2, Ashok Kumar Balaraman3
1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Guwahati, 781101, India.
BMC pulmonary medicine
|January 29, 2025
概括
大麻使用与更高的喘诊断风险有关. 这一系统性审查强调了与大麻消费相关的潜在呼吸系统健康问题,强调了需要提高认识的必要性.
科学领域:
- 公共卫生 公共卫生
- 呼吸系统医学 呼吸系统医学
- 流行病学 流行病学
背景情况:
- 由于合法化趋势,全球大麻使用量正在增加.
- 人们对大麻对呼吸系统健康,特别是喘的影响存在担忧.
- 喘是一个重要的全球公共卫生问题.
研究的目的:
- 系统地审查和整合有关大麻使用与喘风险之间的研究.
- 评估将大麻消费与喘诊断联系在一起的总体证据.
主要方法:
- 在PubMed,Embase和Web of Science进行了全面的文献搜索.
- 包括同行评审的观察性研究,评估大麻消费和喘风险.
- 使用R统计软件进行了随机效应元分析.
主要成果:
- 包括8项涉及1887份记录的研究.
- 1.31 (95% CI: 1.19-1.44) 的合并几率比率表明,使用大麻的喘几率增加.
- 观察到中等异质性 (I2 = 46%),通过敏感性分析证实了强有力的发现.
结论:
- 大麻使用与患喘的可能性增加之间存在显著的关联.
- 调查结果强调了公众对大麻相关呼吸系统风险的认识的重要性.
- 未来的研究应该探索调节因素,如消费频率和模式.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
227
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
227
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


